Methods of enhancing uniform placement of a resin in a subterranean formation

Information

  • Patent Grant
  • 7500521
  • Patent Number
    7,500,521
  • Date Filed
    Thursday, July 6, 2006
    18 years ago
  • Date Issued
    Tuesday, March 10, 2009
    15 years ago
Abstract
Methods of enhancing uniform placement of a resin in a subterranean formation comprising: introducing a preflush fluid comprising an oil-soluble diverting agent into a portion of a subterranean formation; introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation; allowing the oil-soluble diverting agent to at least partially dissolve; and allowing the resin to at least partially consolidate at least a portion of the subterranean formation. Optionally, afterflush fluids may be used as desired.
Description
BACKGROUND

The present invention relates to the treatment of subterranean formations. More particularly, the present invention relates to methods of enhancing uniform placement of a resin in a subterranean formation.


Hydrocarbon wells are often located in subterranean formations that contain unconsolidated particulates (e.g., sand, gravel, proppant, fines, etc.) that may migrate out of the subterranean formation with the oil, gas, water, and/or other fluids produced by the wells. The presence of such particulates in produced fluids is undesirable in that the particulates may abrade pumping and other producing equipment and/or reduce the production of desired fluids from the well. Moreover, particulates that have migrated into a well bore (e.g., inside the casing and/or perforations in a cased hole), among other things, may clog portions of the well bore, hindering the production of desired fluids from the well. The term “unconsolidated particulates,” and derivatives thereof, is defined herein to include loose particulates and particulates bonded with insufficient bond strength to withstand the forces created by the production of fluids through the formation. Unconsolidated particulates may comprise, among other things, sand, gravel, fines and/or proppant particulates in the subterranean formation, for example, proppant particulates placed in the subterranean formation in the course of a fracturing or gravel-packing operation. The terms “unconsolidated subterranean formations,” “unconsolidated portions of a subterranean formation,” and derivatives thereof are defined herein to include any formations that contain unconsolidated particulates, as that term is defined herein. “Unconsolidated subterranean formations,” and “unconsolidated portions of a subterranean formation,” as those terms are used herein, include subterranean fractures wherein unconsolidated particulates reside within the open space of the fracture (e.g., forming a proppant pack within the fracture).


One method of controlling particulates in such unconsolidated formations has been to produce fluids from the formations at low flow rates, so that the near well stability of sand bridges and the like may be substantially preserved. The collapse of such sand bridges, however, may nevertheless occur, possibly due to unintentionally high production rates and/or pressure cycling as may occur from repeated shut-ins and start ups of a well. The frequency of pressure cycling is critical to the longevity of the near well formation, especially during the depletion stage of the well when the pore pressure of the formation has already been significantly reduced.


Another method of controlling particulates in unconsolidated formations involves placing a filtration bed containing gravel (e.g., a “gravel pack”) near the well bore to present a physical barrier to the transport of unconsolidated formation fines with the production of desired fluids. Typically, such “gravel-packing operations” involve the pumping and placement of a quantity of certain particulates into the unconsolidated formation in an area adjacent to a well bore. One common type of gravel-packing operation involves placing a screen in the well bore and packing the surrounding annulus between the screen and the well bore with gravel of a specific size designed to prevent the passage of formation sand. The screen is generally a filter assembly used to retain the gravel placed during the gravel-pack operation. A wide range of sizes and screen configurations are available to suit the characteristics of the gravel-pack sand used. Similarly, a wide range of sizes of gravel is available to suit the characteristics of the unconsolidated particulates in the subterranean formation. To install the gravel pack, the gravel is carried to the formation in the form of a slurry by mixing the gravel with a treatment fluid, which is usually viscosified. Once the gravel is placed in the well bore, the viscosity of the treatment fluid may be reduced, and it is returned to the surface. The resulting structure presents a barrier to migrating sand from the formation while still permitting fluid flow.


However, the use of such gravel-packing methods may be problematic. For example, gravel packs may be time consuming and expensive to install. Due to the time and expense needed, it is sometimes desirable to place a screen without the gravel. Even in circumstances in which it is practical to place a screen without gravel, it is often difficult to determine an appropriate screen size to use as formation sands tend to have a wide distribution of grain sizes. When small quantities of sand are allowed to flow through a screen, formation erosion becomes a significant concern. As a result, the placement of gravel as well as the screen is often necessary to assure that the formation sands are controlled. Expandable sand screens have been developed and implemented in recent years. As part of the installation, an expandable sand screen may be expanded against the well bore, cased hole, or open hole for sand control purposes without the need for gravel packing. However, expandable screens may still exhibit such problems as screen erosion and screen plugging.


Another method used to control particulates in unconsolidated formations involves consolidating unconsolidated particulates into stable, permeable masses by applying a consolidating agent (e.g., a resin or tackifying agent) to the subterranean formation. Such resin application may be problematic when, for example, an insufficient amount of spacer fluid is used between the application of the resin and the application of the external catalyst. The resin may come into contact with the external catalyst in the well bore itself rather than in the unconsolidated subterranean producing zone. When resin is contacted with an external catalyst, an exothermic reaction occurs that may result in rapid polymerization, potentially damaging the formation by plugging pore channels, halting pumping when the well bore is plugged with solid material, or resulting in a downhole explosion as a result of the heat of polymerization. Uniform placement of curable resin into the formations having long intervals is most desirable. However, formations often comprise a wide range of permeabilities even within a single reservoir located along a well bore. As a result, using these conventional processes to treat long intervals (e.g., over about 20 feet) of unconsolidated regions has often heretofore resulted in non-uniform, limited, and/or inadequate penetration distances of consolidating agents into formations.


SUMMARY

The present invention relates to the treatment of subterranean formations. More particularly, the present invention relates to methods of enhancing uniform placement of resin in a subterranean formation.


One embodiment of the present invention is a method comprising: introducing a preflush fluid comprising an oil-soluble diverting agent into a portion of a subterranean formation; introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation; allowing the oil-soluble diverting agent to at least partially dissolve; and allowing the resin to at least partially consolidate at least a portion of the subterranean formation.


Another embodiment of the present invention is a method comprising: introducing a preflush fluid comprising an oil-soluble diverting agent into a portion of a subterranean formation; introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation; allowing the resin to at least partially dissolve the oil-soluble diverting agent; introducing an afterflush fluid comprising an oil soluble diverting agent into a portion of a subterranean formation; and allowing the afterflush fluid to at least partially dissolve the aqueous soluble diverting agent.


The features and advantages of the present invention will be apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.







DESCRIPTION OF PREFERRED EMBODIMENTS

The present invention relates to the treatment of subterranean formations. More particularly, the present invention relates to methods of enhancing uniform placement of a resin in a subterranean formation.


I. Methods of the Present Invention


The methods of the present invention generally comprise: introducing a pre-flush fluid comprising an oil-soluble diverting agent into a portion of a subterranean formation; introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation; allowing the oil soluble diverting agent to at least partially dissolve; and allowing the resin to at least partially consolidate at least a portion of the subterranean formation. The resin and aqueous soluble diverting agents may be provided and/or introduced into the subterranean formation as a component of one or more treatment fluids introduced into the subterranean formation. The term “diverting agent,” is defined herein to include any substance whose presence may, at least in part, ensure substantially uniform injection of a treatment fluid over the region of the subterranean formation to be treated.


The subterranean formations treated in the methods of the present invention may be any subterranean formation wherein at least a plurality of unconsolidated particulates resides in the formation. The subterranean formation may be penetrated by a well bore through which the resin and/or other treatment fluids may be introduced. A well bore penetrating the subterranean formation being treated may contain one or more casing strings (e.g., “cased” or “partially cased”), or the well bore may be uncased. Such a well bore optionally may contain one or more screens (e.g., gravel packs) to, inter alia, provide some degree of sand control in the well.


The methods of the present invention include introducing one or more preflush fluids comprising an oil soluble diverting agent into the subterranean formation at any stage of the treatment process. The term “preflush fluid” is defined herein to include any fluid (e.g., a liquid, a gel, a gas, or combination thereof) that may be introduced into a subterranean formation prior to some other process or occurrence in the subterranean formation, and does not require any particular action by the preflush fluid. The preflush fluid may be introduced into the subterranean formation using any means suitable for introducing fluids into the subterranean formation. Typically, a preflush fluid may be introduced into the subterranean formation at any time before the resin is introduced into the subterranean formation. The preflush fluids used in the methods of the present invention further comprise an oil soluble diverting agent. The oil-soluble diverting agent may at least partially ensure substantially uniform injection of a consolidating treatment fluid over the region of the subterranean formation to be treated. In certain embodiments, a preflush fluid may be applied to the subterranean formation, among other purposes, to clean out undesirable substances (e.g., oil, residue, or debris) from the pore spaces in the matrix of the subterranean formation and/or to prepare the subterranean formation for later placement of the resin. For example, an acidic preflush fluid may be introduced into at least a portion of the subterranean formation that may, inter alia, dissolve undesirable substances in the subterranean formation. Generally, the volume of the preflush fluid introduced into the formation ranges from about 0.1 times to about 50 times the volume of the resin. Examples of preflush fluids that may be suitable for use with the present invention are described in more detail in Section II.A below.


The methods of the present invention optionally may include applying one or more afterflush fluids into the subterranean formation at any stage of the treatment process. The term “afterflush fluid” is defined herein to include any fluid (e.g., a liquid, a gel, a gas, or combination thereof) that may be introduced into a subterranean formation after some other process or occurrence in the subterranean formation, and does not require any particular action by or purpose of the afterflush fluid. Where used, the afterflush fluid may be introduced into the subterranean formation using any means suitable for introducing fluids into the subterranean formation. Typically, injection of an afterflush fluid may occur at any time after the resin is introduced into the subterranean formation. When used, the afterflush fluid is preferably placed into the subterranean formation while the resin is still in a flowing state. For example, an afterflush fluid may be placed into the formation prior to a shut-in period. Optionally, the afterflush may further comprise an oil soluble diverting agent. In certain embodiments, an afterflush fluid may be applied to the subterranean formation, among other purposes, to restore the permeability of a portion of the subterranean formation by displacing at least a portion of the resin from the pore channels therein or forcing the displaced portion of the resin further into the subterranean formation where it may have negligible impact on subsequent hydrocarbon production. Generally, the volume of afterflush fluid introduced into the subterranean formation ranges from about 0.1 times to about 50 times the volume of the resin. In some embodiments of the present invention, the volume of afterflush fluid introduced into the subterranean formation ranges from about 0.1 times to about 5 times the volume of the resin. Examples of afterflush fluids that may be suitable for use with the present invention are described in more detail in Section II.A below.


According to the methods of the present invention, after placement of the resin, the subterranean formation may be shut in for a period of time to allow the resin composition to transform a portion of the subterranean formation into a consolidated region. The shutting-in of the well bore for a period of time may, inter alia, stabilize unconsolidated portions of the subterranean formation, for example, by enhancing the curing of the resin between formation particulates. Typically, the shut-in period of the well bore occurs after placement of the resin. In embodiments using an afterflush fluid, the shut-in period preferably occurs after the use of the afterflush fluid. The optional shut-in time period is dependent, among other things, on the composition of the resin used and the temperature of the formation. Generally, the chosen period of time will be between about 0.5 hours and about 72 hours or longer. Determining the proper period of time to shut in the formation is within the ability of one skilled in the art with the benefit of this disclosure.


The methods of the present invention optionally may comprise performing one or more additional subterranean treatments for a variety of different purposes, for example, to restore the permeability of a portion of the subterranean formation that has undergone a consolidation treatment (including, but not limited to, a treatment performed according to a method of the present invention). These additional treatments may be performed prior to, during, or subsequent to performing all or some part of a method of the present invention. As used herein, the term “treatment,” or “treating,” refers to any subterranean operation performed in conjunction with a desired function and/or for a desired purpose. The term “treatment,” or “treating,” does not imply any particular action.


In certain embodiments, one or more fractures may be created or enhanced in a portion of the subterranean formation, among other purposes, to at least partially restore the permeability of the portion of the subterranean formation and reconnect the well bore with portions of the formation (e.g., the reservoir formation) outside the consolidated region. “Enhancing” one or more fractures in a subterranean formation, as that term is used herein, refers to the extension or enlargement of one or more new, natural, or previously created fractures in the subterranean formation. This fracturing may be accomplished by any means known by a person skilled in the art for creating or enhancing one or more fractures in a subterranean formation. For example, a hydraulic fracturing treatment may be used wherein a fluid (e.g., a fracturing fluid, a fluid comprising the relative permeability modifier) is introduced into the subterranean formation at a pressure sufficient to create or enhance one or more fractures in the formation. In certain embodiments, the fluid used in the hydraulic fracturing treatment may comprise a viscosified fluid (e.g., a fluid comprising a gelling agent, a crosslinked gelling agent, a surfactant, or a combination thereof). In certain embodiments, a fluid (e.g., a fracturing fluid) comprising proppant particulates may be introduced into the subterranean formation, and the proppant particulates therein may be deposited in the fracture, among other purposes, to maintain fluid conductivity of the fracture. The proppant may be coated with a curable resin or consolidating agent to form a hard, permeable solid mass in the fracture or fractures, among other things, to prevent proppant flow back during production from the well. The proppant also may be blended with fibrous particulates to form a stable network with the proppant and also partially control proppant flow back.


II. Fluids, Resins, and Diverging Agents


A. Fluids


In certain embodiments, the resin may be provided and/or introduced into the subterranean formation as a component of one or more treatment fluids introduced into the subterranean formation. These treatment fluids may include any non-aqueous based fluid that does not adversely interact with the other components used in accordance with this invention or with the subterranean formation. Non-aqueous based treatment fluids may comprise one or more organic liquids, such as hydrocarbons (e.g., kerosene, xylene, toluene, or diesel), oils (e.g., mineral oils or synthetic oils), esters, and the like.


The preflush and afterflush fluids utilized in certain embodiments of the present invention may include any aqueous based fluid that does not adversely interact with the other components used in accordance with this invention or with the subterranean formation. Aqueous base fluids may comprise fresh water, salt water, brine, or seawater, or any other aqueous fluid that does not adversely react with the other components used in accordance with this invention or with the subterranean formation. In certain embodiments, a preflush or afterflush fluid may comprise a surfactant. Any surfactant compatible with later-used treatments (e.g., a resin) may be used in the present invention, for example, to aid a resin in flowing to the contact points between adjacent particulates in the formation. Such surfactants include, but are not limited to, ethoxylated nonyl phenol phosphate esters, mixtures of one or more cationic surfactants, one or more non-ionic surfactants, and an alkyl phosphonate surfactant. Suitable mixtures of one or more cationic and nonionic surfactants are described in U.S. Pat. No. 6,311,773, the relevant disclosure of which is incorporated herein by reference. A C12-C22 alkyl phosphonate surfactant is preferred. The surfactant or surfactants used may be included in the preflush or afterflush fluid in an amount sufficient to prepare the subterranean formation to receive a consolidation treatment. In some embodiments of the present invention, the surfactant is present in the preflush or afterflush fluid in an amount in the range of from about 0.1% to about 10% by weight of the aqueous fluid.


The treatment fluids, preflush fluids, and/or afterflush fluids utilized in methods of the present invention may comprise any number of additional additives, including, but not limited to, salts, surfactants, acids, fluid loss control additives, gas, foamers, corrosion inhibitors, scale inhibitors, catalysts, clay control agents, biocides, friction reducers, antifoam agents, bridging agents, dispersants, flocculants, H2S scavengers, CO2 scavengers, oxygen scavengers, lubricants, viscosifiers, breakers, weighting agents, particulate materials (e.g., proppant particulates) and the like. In certain embodiments the treatment fluids, preflush fluids, and/or afterflush fluids may comprise an activator or catalyst which may be used, inter alia, to activate the polymerization of the resin. A person skilled in the art, with the benefit of this disclosure, will recognize the types of additives that may be included in the treatment fluids, preflush fluids, and/or afterflush fluids for a particular application.


B. Resins


Resins suitable for use in the present invention include any resin that is capable of forming a hardened, consolidated mass. The term “resin” as used herein includes any of numerous physically similar polymerized synthetics or chemically modified natural resins, including but not limited to thermoplastic materials and thermosetting materials. Many such resins are commonly used in subterranean consolidation operations, and some suitable resins include two component epoxy based resins, novolak resins, polyepoxide resins, phenol-aldehyde resins, urea-aldehyde resins, urethane resins, phenolic resins, furan resins, furan/furfuryl alcohol resins, phenolic/latex resins, phenol formaldehyde resins, polyester resins and hybrids and copolymers thereof, polyurethane resins and hybrids and copolymers thereof, acrylate resins, and mixtures thereof. Some suitable resins, such as epoxy resins, may be cured with an internal catalyst or activator so that when pumped downhole, they may be cured using only time and temperature. Other suitable resins, such as furan resins generally require a time-delayed catalyst or an external catalyst to help activate the polymerization of the resins if the cure temperature is low (i.e., less than 250° F.) but will cure under the effect of time and temperature if the formation temperature is above about 250° F., preferably above about 300° F. It is within the ability of one skilled in the art, with the benefit of this disclosure, to select a suitable resin for use in embodiments of the present invention and to determine whether a catalyst is required to trigger curing.


Selection of a suitable resin may be affected by the temperature of the subterranean formation to which the fluid will be introduced. By way of example, for subterranean formations having a bottom hole static temperature (“BHST”) ranging from about 60° F. to about 250° F., two component epoxy based resins comprising a hardenable resin component and a hardening agent component containing specific hardening agents may be preferred. For subterranean formations having a BHST ranging from about 300° F. to about 600° F., a furan based resin may be preferred. For subterranean formations having a BHST ranging from about 200° F. to about 400° F., either a phenolic based resin or a one component HT epoxy based resin may be suitable. For subterranean formations having a BHST of at least about 175° F., a phenol/phenol formaldehyde/furfuryl alcohol resin may also be suitable.


Any solvent that is compatible with the chosen resin and achieves the desired viscosity effect is suitable for use in the present invention. Some preferred solvents are those having high flash points (e.g., about 125° F.) because of, among other things, environmental and safety concerns; such solvents include butyl lactate, butylglycidyl ether, dipropylene glycol methyl ether, dipropylene glycol dimethyl ether, dimethyl formamide, diethyleneglycol methyl ether, ethyleneglycol butyl ether, diethyleneglycol butyl ether, propylene carbonate, methanol, butyl alcohol, d-limonene, fatty acid methyl esters, and combinations thereof. Other preferred solvents include aqueous dissolvable solvents such as, methanol, isopropanol, butanol, glycol ether solvents, and combinations thereof. Suitable glycol ether solvents include, but are not limited to, diethylene glycol methyl ether, dipropylene glycol methyl ether, 2-butoxy ethanol, ethers of a C2 to C6 dihydric alkanol containing at least one C1 to C6 alkyl group, mono ethers of dihydric alkanols, methoxypropanol, butoxyethanol, hexoxyethanol, and isomers thereof. Selection of an appropriate solvent is dependent on the resin chosen and is within the ability of one skilled in the art with the benefit of this disclosure.


C. Diverting Agents


Suitable diverting agents for use in the present invention include any substance whose presence may, at least in part, ensure substantially uniform injection of a treatment fluid over the region of the subterranean formation to be treated. As injected fluids tend to follow the path of least resistance, the least permeable areas of the subterranean formation may receive inadequate treatment. By using a diverting agent, a treatment may be focused on an area where the treatment is most desired. Additionally, the diversion effect of the diverting agent should preferably be temporary to enable productivity of the well after treatment. Examples of suitable diverting agents include aqueous soluble diverting agents and oil soluble diverting agents.


1. Aqueous Soluble Diverting Agents


Aqueous soluble diverting agents suitable for use in the methods of the present invention may comprise any aqueous soluble diverting agent capable of degrading and/or dissolving in the presence of an aqueous based fluid. In one embodiment, a resin and an aqueous soluble diverting agent may be introduced into the subterranean formation and the resin may then be diverted by the diverting agent. Examples of suitable aqueous soluble diverting agents include KCl, NaCl, NH4Cl, CaCl2, and rock salt.


2. Oil Soluble Diverting Agents


Oil soluble diverting agents suitable for use in the methods of the present invention may comprise any oil soluble diverting agent capable of degrading and/or dissolving in the presence of an oil based fluid. In one embodiment, a preflush fluid comprising an oil soluble diverting agent, and optionally an afterflush fluid comprising an oil soluble diverting agent, may be introduced into the subterranean formation and the preflush and/or afterflush may then be diverted by the diverting agent. Examples of suitable oil soluble diverting agents include napthalene, xylene, toluene, benzene, ethyl benzene, crude oil, mineral oil, oil-soluble resin particulates, and emulsions with an oil phase.


Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. While numerous changes may be made by those skilled in the art, such changes are encompassed within the spirit of this invention as defined by the appended claims. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the present invention. In particular, every range of values (e.g., “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood as referring to the power set (the set of all subsets) of the respective range of values. The terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee.

Claims
  • 1. A method comprising: introducing a preflush fluid comprising an oil-soluble diverting agent into a portion of a subterranean formation;introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation;allowing the oil-soluble diverting agent to at least partially dissolve;introducing an afterflush fluid comprising an oil soluble diverting agent into a portion of a subterranean formation; andallowing the resin to at least partially consolidate at least a portion of the subterranean formation.
  • 2. The method of claim 1 wherein the resin is selected from the group consisting of a two component epoxy based resin, novolak resin, polyepoxide resin, phenol-aldehyde resin, urea-aldehyde resin, urethane resin, phenolic resin, furan resin, furan/furfuryl alcohol resin, phenolic/latex resin, phenol formaldehyde resin, polyester resin and hybrids and copolymers thereof, polyurethane resin and hybrids and copolymers thereof, acrylate resin, and mixtures thereof.
  • 3. The method of claim 1 wherein the oil soluble diverting agent is selected from the group consisting of napthalene, xylene, toluene, benzene, ethyl benzene, crude oil, mineral oil, emulsions with an oil phase, and combinations thereof.
  • 4. The method of claim 1 wherein the aqueous soluble diverting agent is selected from the group consisting of KCl, NaCl, NH4Cl, CaCl2, rock salt and combinations thereof.
  • 5. The method of claim 1 wherein introducing the resin into the subterranean formation occurs after introducing the preflush fluid into an unconsolidated portion of a subterranean formation.
  • 6. The method of claim 1 wherein the preflush fluid is selected from the group consisting of fresh water, salt water, brine, and seawater.
  • 7. The method of claim 1 wherein the afterflush fluid is selected from the group consisting of fresh water, salt water, brine, and seawater.
  • 8. The method of claim 1 further comprising the step of allowing the afterflush fluid to at least partially dissolve the aqueous soluble diverting agent.
  • 9. The method of claim 1 wherein the preflush fluid is introduced into the subterranean formation in an amount in the range of from about 0.1 times to about 50 times the volume of the resin.
  • 10. A method comprising: introducing a preflush fluid comprising an oil-soluble diverting agent into a portion of a subterranean formation;introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation;allowing the resin to at least partially dissolve the oil-soluble diverting agent;introducing an afterflush fluid comprising an oil soluble diverting agent into a portion of a subterranean formation; andallowing the afterflush fluid to at least partially dissolve the aqueous soluble diverting agent.
  • 11. The method of claim 10 wherein the resin is selected from the group consisting of a two component epoxy based resin, novolak resin, polyepoxide resin, phenol-aldehyde resin, urea-aldehyde resin, urethane resin, phenolic resin, furan resin, furan/furfuryl alcohol resin, phenolic/latex resin, phenol formaldehyde resin, polyester resin and hybrids and copolymers thereof, polyurethane resin and hybrids and copolymers thereof, acrylate resin, and mixtures thereof.
  • 12. The method of claim 10 wherein the oil soluble diverting agent is selected from the group consisting of napthalene, xylene, toluene, benzene, ethyl benzene, crude oil, mineral oil, emulsions with an oil phase, and combinations thereof.
  • 13. The method of claim 10 wherein the aqueous soluble diverting agent is selected from the group consisting of KCl, NaCl, NH4Cl, CaCl2, rock salt and combinations thereof.
  • 14. The method of claim 10 wherein introducing the resin into the subterranean formation occurs after introducing the preflush fluid into an unconsolidated portion of a subterranean formation.
  • 15. The method of claim 10 wherein introducing the afterflush fluid into the subterranean formation occurs after introducing the resin and the aqueous soluble diverting agent into an unconsolidated portion of a subterranean formation.
  • 16. The method of claim 10 wherein the pre-flush fluid is selected from the group consisting of fresh water, salt water, brine, and seawater.
  • 17. The method of claim 10 wherein the afterflush fluid is selected from the group consisting of fresh water, salt water, brine, and seawater.
  • 18. The method of claim 10 wherein the preflush fluid is introduced into the subterranean formation in an amount in the range of from about 0.1 times to about 50 times the volume of the resin.
  • 19. A method comprising: introducing a preflush fluid comprising an oil-soluble diverting agent and at least one fluid selected from the group consisting of fresh water, salt water, brine, and seawater into a portion of a subterranean formation;introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation;allowing the oil-soluble diverting agent to at least partially dissolve; andallowing the resin to at least partially consolidate at least a portion of the subterranean formation.
US Referenced Citations (651)
Number Name Date Kind
2238671 Woodhouse Apr 1941 A
2703316 Schneider Mar 1955 A
2869642 McKay et al. Jan 1959 A
3047067 Williams et al. Jul 1962 A
3052298 Malott Sep 1962 A
3070165 Stratton Dec 1962 A
3123138 Robichaux Mar 1964 A
3173484 Huitt et al. Mar 1965 A
3176768 Brandt et al. Apr 1965 A
3189091 Bearden et al. Jun 1965 A
3195635 Fast Jul 1965 A
3199590 Young Aug 1965 A
3272650 MacVittie Sep 1966 A
3297086 Spain Jan 1967 A
3302719 Fischer Feb 1967 A
3308885 Sandiford Mar 1967 A
3308886 Evans Mar 1967 A
3316965 Watanabe May 1967 A
3329204 Brieger Jul 1967 A
3336980 Rike Aug 1967 A
3364995 Atkins et al. Jan 1968 A
3366178 Malone et al. Jan 1968 A
3375872 McLaughlin et al. Apr 1968 A
3378074 Kiel Apr 1968 A
3404735 Young et al. Oct 1968 A
3415320 Young Dec 1968 A
3419073 Brooks, Jr. Dec 1968 A
3443386 Copeland et al. May 1969 A
3455390 Gallus Jul 1969 A
3478824 Hess et al. Nov 1969 A
3481403 Gidley et al. Dec 1969 A
3481404 Gidley Dec 1969 A
3489222 Millhone et al. Jan 1970 A
3492147 Young et al. Jan 1970 A
3525398 Fisher Aug 1970 A
3565176 Clifford Feb 1971 A
3592266 Tinsley Jul 1971 A
3659651 Graham May 1972 A
3681287 Brown et al. Aug 1972 A
3708013 Dismukes Jan 1973 A
3709298 Pramann Jan 1973 A
3709641 Sarem Jan 1973 A
3741308 Veley Jun 1973 A
3754598 Holloway, Jr. Aug 1973 A
3765804 Brandon Oct 1973 A
3768564 Knox et al. Oct 1973 A
3769070 Schitt Oct 1973 A
3784585 Schmitt et al. Jan 1974 A
3819525 Hattenbrun Jun 1974 A
3828854 Templeton et al. Aug 1974 A
3842911 Know et al. Oct 1974 A
3850247 Tinsley Nov 1974 A
3854533 Gurley et al. Dec 1974 A
3857444 Copeland Dec 1974 A
3861467 Harnsberger Jan 1975 A
3863709 Fitch Feb 1975 A
3868998 Lybarger et al. Mar 1975 A
3888311 Cooke, Jr. Jun 1975 A
3912692 Casey et al. Oct 1975 A
3933205 Kiel Jan 1976 A
3948672 Harnberger Apr 1976 A
3955993 Curtice May 1976 A
3960736 Free et al. Jun 1976 A
4000781 Knapp Jan 1977 A
4008763 Lowe et al. Feb 1977 A
4015995 Hess Apr 1977 A
4018285 Watkins et al. Apr 1977 A
4029148 Emery Jun 1977 A
4031958 Sandiford et al. Jun 1977 A
4042032 Anderson et al. Aug 1977 A
4060988 Arnold Dec 1977 A
4068718 Cooke, Jr. et al. Jan 1978 A
4070865 McLaughlin Jan 1978 A
4074760 Copeland et al. Feb 1978 A
4085801 Sifferman et al. Apr 1978 A
4085802 Sifferman et al. Apr 1978 A
4089437 Chutter et al. May 1978 A
4127173 Watkins et al. Nov 1978 A
4169798 DeMartino Oct 1979 A
4172066 Zweigle et al. Oct 1979 A
4245702 Haafkens et al. Jan 1981 A
4247430 Constien Jan 1981 A
4259205 Murphey Mar 1981 A
4273187 Satter et al. Jun 1981 A
4291766 Davies et al. Sep 1981 A
4305463 Zakiewicz Dec 1981 A
4336842 Graham et al. Jun 1982 A
4352674 Fery Oct 1982 A
4353806 Canter et al. Oct 1982 A
4387769 Erbstoesser et al. Jun 1983 A
4392988 Dobson et al. Jul 1983 A
4399866 Dearth Aug 1983 A
4415805 Fertl et al. Nov 1983 A
4428427 Friedman Jan 1984 A
4439489 Johnson et al. Mar 1984 A
4441556 Powers et al. Apr 1984 A
4443347 Underdown et al. Apr 1984 A
4460052 Gockel Jul 1984 A
4470915 Conway Sep 1984 A
4493875 Beck et al. Jan 1985 A
4494605 Wiechel et al. Jan 1985 A
4498995 Gockel Feb 1985 A
4501328 Nichols Feb 1985 A
4526695 Erbstosser et al. Jul 1985 A
4527627 Graham et al. Jul 1985 A
4541489 Wu Sep 1985 A
4546012 Brooks Oct 1985 A
4553596 Graham et al. Nov 1985 A
4564459 Underdown et al. Jan 1986 A
4572803 Yamazoe et al. Feb 1986 A
4585064 Graham et al. Apr 1986 A
4649998 Friedman Mar 1987 A
4664819 Glaze et al. May 1987 A
4665988 Murphey et al. May 1987 A
4669543 Young Jun 1987 A
4670501 Dymond et al. Jun 1987 A
4675140 Sparks et al. Jun 1987 A
4681165 Bannister Jul 1987 A
4683954 Walker et al. Aug 1987 A
4694905 Armbruster Sep 1987 A
4715967 Bellis Dec 1987 A
4716964 Erbstoesser et al. Jan 1988 A
4733729 Copeland Mar 1988 A
4739832 Jennings, Jr. et al. Apr 1988 A
4772646 Harms et al. Sep 1988 A
4777200 Dymond et al. Oct 1988 A
4785884 Armbruster Nov 1988 A
4787453 Hewgill et al. Nov 1988 A
4789105 Hosokawa et al. Dec 1988 A
4796701 Hudson et al. Jan 1989 A
4797262 Dewitz Jan 1989 A
4800960 Friedman et al. Jan 1989 A
4809783 Hollenbeck et al. Mar 1989 A
4817721 Pober Apr 1989 A
4829100 Murphey et al. May 1989 A
4838352 Oberste-Padtberg et al. Jun 1989 A
4842070 Sharp Jun 1989 A
4842072 Friedman et al. Jun 1989 A
4843118 Lai et al. Jun 1989 A
4848467 Cantu et al. Jul 1989 A
4848470 Korpics Jul 1989 A
4850430 Copeland et al. Jul 1989 A
4875525 Mana Oct 1989 A
4886354 Welch et al. Dec 1989 A
4888240 Graham et al. Dec 1989 A
4892147 Jennings, Jr. et al. Jan 1990 A
4895207 Friedman et al. Jan 1990 A
4898750 Friedman et al. Feb 1990 A
4903770 Friedman et al. Feb 1990 A
4921576 Hurd May 1990 A
4934456 Moradi-Araghi Jun 1990 A
4936385 Weaver et al. Jun 1990 A
4942186 Murphey et al. Jul 1990 A
4957165 Cantu et al. Sep 1990 A
4959432 Fan et al. Sep 1990 A
4961466 Himes et al. Oct 1990 A
4969522 Whitehurst et al. Nov 1990 A
4969523 Martin et al. Nov 1990 A
4984635 Cullick et al. Jan 1991 A
4986353 Clark et al. Jan 1991 A
4986354 Cantu et al. Jan 1991 A
4986355 Casad et al. Jan 1991 A
5030603 Rumpf et al. Jul 1991 A
5049743 Taylor, III et al. Sep 1991 A
5056597 Stowe, III et al. Oct 1991 A
5082056 Tackett, Jr. Jan 1992 A
5095987 Weaver et al. Mar 1992 A
5105886 Strubhar et al. Apr 1992 A
5107928 Hilterhaus Apr 1992 A
5128390 Murphey et al. Jul 1992 A
5135051 Fracteau et al. Aug 1992 A
5142023 Gruber et al. Aug 1992 A
5165438 Fracteau et al. Nov 1992 A
5173527 Calve Dec 1992 A
5178218 Dees Jan 1993 A
5182051 Bandy et al. Jan 1993 A
5199491 Kutts et al. Apr 1993 A
5199492 Surles et al. Apr 1993 A
5211234 Floyd May 1993 A
5216050 Sinclair Jun 1993 A
5218038 Johnson et al. Jun 1993 A
5232955 Caabai et al. Aug 1993 A
5232961 Murphey et al. Aug 1993 A
5238068 Fredickson Aug 1993 A
5244362 Conally Sep 1993 A
5247059 Gruber et al. Sep 1993 A
5249627 Harms et al. Oct 1993 A
5249628 Surjaatmadja Oct 1993 A
5256729 Kutts et al. Oct 1993 A
5265678 Grundmann Nov 1993 A
5273115 Spafford Dec 1993 A
5278203 Harms Jan 1994 A
5285849 Surles et al. Feb 1994 A
5293939 Surles et al. Mar 1994 A
5295542 Cole et al. Mar 1994 A
5320171 Laramay Jun 1994 A
5321062 Landrum et al. Jun 1994 A
5325923 Surjaatmadja et al. Jul 1994 A
5330005 Card et al. Jul 1994 A
5332037 Schmidt et al. Jul 1994 A
5335726 Rodrogues Aug 1994 A
5351754 Hardin et al. Oct 1994 A
5358051 Rodrigues Oct 1994 A
5359026 Gruber Oct 1994 A
5360068 Sprunt et al. Nov 1994 A
5361856 Surjaatmajda et al. Nov 1994 A
5363916 Himes et al. Nov 1994 A
5373901 Norman et al. Dec 1994 A
5377756 Northrop et al. Jan 1995 A
5377759 Surles Jan 1995 A
5381864 Nguyen et al. Jan 1995 A
5386874 Laramay et al. Feb 1995 A
5388648 Jordan, Jr. Feb 1995 A
5390741 Payton et al. Feb 1995 A
5393810 Harris et al. Feb 1995 A
5396957 Surjaatmadja et al. Mar 1995 A
5402846 Jennings, Jr. et al. Apr 1995 A
5403822 Mueller et al. Apr 1995 A
5420174 Dewprashad May 1995 A
5422183 Sinclair et al. Jun 1995 A
5423381 Surles et al. Jun 1995 A
5439055 Card et al. Aug 1995 A
5460226 Lawton et al. Oct 1995 A
5464060 Hale et al. Nov 1995 A
5475080 Gruber et al. Dec 1995 A
5484881 Gruber et al. Jan 1996 A
5492177 Yeh et al. Feb 1996 A
5492178 Nguyen et al. Feb 1996 A
5494103 Surjaatmadja et al. Feb 1996 A
5494178 Nguyen et al. Feb 1996 A
5497830 Boles et al. Mar 1996 A
5498280 Fistner et al. Mar 1996 A
5499678 Surjaatmadja et al. Mar 1996 A
5501275 Card et al. Mar 1996 A
5505787 Yamaguchi Apr 1996 A
5512071 Yam et al. Apr 1996 A
5520250 Harry et al. May 1996 A
5522460 Shu Jun 1996 A
5529123 Carpenter et al. Jun 1996 A
5531274 Bienvenu, Jr. Jul 1996 A
5536807 Gruber et al. Jul 1996 A
5545824 Stengel et al. Aug 1996 A
5547023 McDaniel et al. Aug 1996 A
5551513 Suries et al. Sep 1996 A
5551514 Nelson et al. Sep 1996 A
5582249 Caveny et al. Dec 1996 A
5582250 Constein Dec 1996 A
5588488 Vijn et al. Dec 1996 A
5591700 Harris et al. Jan 1997 A
5594095 Gruber et al. Jan 1997 A
5595245 Scott, III Jan 1997 A
5597784 Sinclair et al. Jan 1997 A
5604184 Ellis et al. Feb 1997 A
5604186 Hunt et al. Feb 1997 A
5609207 Dewprashad et al. Mar 1997 A
5620049 Gipson et al. Apr 1997 A
5639806 Johnson et al. Jun 1997 A
5663123 Goodhue, Jr. et al. Sep 1997 A
5670473 Scepanski Sep 1997 A
5692566 Surles Dec 1997 A
5697440 Weaver et al. Dec 1997 A
5697448 Johnson Dec 1997 A
5698322 Tsai et al. Dec 1997 A
5701956 Hardy et al. Dec 1997 A
5712314 Surles et al. Jan 1998 A
5732364 Kalb et al. Mar 1998 A
5738136 Rosenberg Apr 1998 A
5765642 Surjaatmadja Jun 1998 A
5775425 Weaver et al. Jul 1998 A
5782300 James et al. Jul 1998 A
5783822 Buchanan et al. Jul 1998 A
5787986 Weaver et al. Aug 1998 A
5791415 Nguyen et al. Aug 1998 A
5799734 Norman et al. Sep 1998 A
5806593 Suries Sep 1998 A
5830987 Smith Nov 1998 A
5833000 Weaver et al. Nov 1998 A
5833361 Funk Nov 1998 A
5836391 Jonasson et al. Nov 1998 A
5836392 Urlwin-Smith Nov 1998 A
5836393 Johnson Nov 1998 A
5837656 Sinclair et al. Nov 1998 A
5837785 Kinsho et al. Nov 1998 A
5839510 Weaver et al. Nov 1998 A
5840784 Funkhouser et al. Nov 1998 A
5849401 El-Afandi et al. Dec 1998 A
5849590 Anderson, II et al. Dec 1998 A
5853048 Weaver et al. Dec 1998 A
5864003 Qureshi et al. Jan 1999 A
5865936 Edelman et al. Feb 1999 A
5871049 Weaver et al. Feb 1999 A
5873413 Chatterji et al. Feb 1999 A
5875844 Chatterji et al. Mar 1999 A
5875845 Chatterji et al. Mar 1999 A
5875846 Chatterji et al. Mar 1999 A
5893383 Fracteau Apr 1999 A
5893416 Read Apr 1999 A
5901789 Donnelly et al. May 1999 A
5908073 Nguyen et al. Jun 1999 A
5911282 Onan et al. Jun 1999 A
5916933 Johnson et al. Jun 1999 A
5921317 Dewprashad et al. Jul 1999 A
5924488 Nguyen et al. Jul 1999 A
5929437 Elliott et al. Jul 1999 A
5944105 Nguyen Aug 1999 A
5944106 Dalrymple et al. Aug 1999 A
5945387 Chatterji et al. Aug 1999 A
5948734 Sinclair et al. Sep 1999 A
5957204 Chatterji et al. Sep 1999 A
5960784 Ryan Oct 1999 A
5960877 Funkhouser Oct 1999 A
5960878 Nguyen et al. Oct 1999 A
5960880 Nguyen et al. Oct 1999 A
5964291 Bourne et al. Oct 1999 A
5969006 Onan et al. Oct 1999 A
5969823 Wurz et al. Oct 1999 A
5977283 Rossitto Nov 1999 A
5994785 Higuchi et al. Nov 1999 A
RE36466 Nelson et al. Dec 1999 E
6003600 Nguyen et al. Dec 1999 A
6004400 Bishop et al. Dec 1999 A
6006835 Onan et al. Dec 1999 A
6006836 Chatterji et al. Dec 1999 A
6012524 Chatterji et al. Jan 2000 A
6016870 Dewprashad et al. Jan 2000 A
6024170 McCabe et al. Feb 2000 A
6028113 Scepanski Feb 2000 A
6028534 Ciglenec et al. Feb 2000 A
6040398 Kinsho et al. Mar 2000 A
6047772 Weaver et al. Apr 2000 A
6059034 Rickards et al. May 2000 A
6059035 Chatterji et al. May 2000 A
6059036 Chatterji et al. May 2000 A
6063738 Chatterji et al. May 2000 A
6068055 Chatterji et al. May 2000 A
6069117 Onan et al. May 2000 A
6074739 Katagiri Jun 2000 A
6079492 Hoogteijling et al. Jun 2000 A
6098711 Chatterji et al. Aug 2000 A
6114410 Betzold Sep 2000 A
6123871 Carroll Sep 2000 A
6123965 Jacon et al. Sep 2000 A
6124246 Heathman et al. Sep 2000 A
6130286 Thomas et al. Oct 2000 A
6131661 Conner et al. Oct 2000 A
6135987 Tsai et al. Oct 2000 A
6140446 Fujiki et al. Oct 2000 A
6143698 Murphey et al. Nov 2000 A
6148911 Gipson et al. Nov 2000 A
6152234 Newhouse et al. Nov 2000 A
6162766 Muir et al. Dec 2000 A
6165947 Chang et al. Dec 2000 A
6169058 Le et al. Jan 2001 B1
6172011 Card et al. Jan 2001 B1
6172077 Curtis et al. Jan 2001 B1
6176315 Reddy et al. Jan 2001 B1
6177484 Surles Jan 2001 B1
6184311 O'Keefe et al. Feb 2001 B1
6186228 Wegener et al. Feb 2001 B1
6187834 Thayer et al. Feb 2001 B1
6187839 Eoff Feb 2001 B1
6189615 Sydansk Feb 2001 B1
6192985 Hinkel et al. Feb 2001 B1
6192986 Urlwin-Smith Feb 2001 B1
6196317 Hardy Mar 2001 B1
6202751 Chatterji et al. Mar 2001 B1
6209643 Nguyen et al. Apr 2001 B1
6209644 Brunet Apr 2001 B1
6209646 Reddy et al. Apr 2001 B1
6210471 Craig Apr 2001 B1
6214773 Harris et al. Apr 2001 B1
6231644 Chatterji et al. May 2001 B1
6234251 Chatterji et al. May 2001 B1
6238597 Yim et al. May 2001 B1
6241019 Davidson et al. Jun 2001 B1
6242390 Mitchell et al. Jun 2001 B1
6244344 Chatterji et al. Jun 2001 B1
6257335 Nguyen et al. Jul 2001 B1
6260622 Blok et al. Jul 2001 B1
6271181 Chatterji et al. Aug 2001 B1
6274650 Cui Aug 2001 B1
6279652 Chatterji et al. Aug 2001 B1
6279656 Sinclair et al. Aug 2001 B1
6283214 Guinot et al. Sep 2001 B1
6302207 Nguyen et al. Oct 2001 B1
6306998 Kimura et al. Oct 2001 B1
6310008 Rietjens Oct 2001 B1
6311773 Todd et al. Nov 2001 B1
6315040 Donnelly Nov 2001 B1
6321841 Eoff et al. Nov 2001 B1
6323307 Bigg et al. Nov 2001 B1
6326458 Gruber et al. Dec 2001 B1
6328105 Betzold Dec 2001 B1
6328106 Griffith et al. Dec 2001 B1
6330916 Rickards et al. Dec 2001 B1
6330917 Chatterji et al. Dec 2001 B2
6342467 Chang et al. Jan 2002 B1
6350309 Chatterji et al. Feb 2002 B2
6357527 Norman et al. Mar 2002 B1
6364018 Brannon et al. Apr 2002 B1
6364945 Chatterji et al. Apr 2002 B1
6367165 Huttlin Apr 2002 B1
6367549 Chatterji et al. Apr 2002 B1
6372678 Youngsman et al. Apr 2002 B1
6376571 Chawla et al. Apr 2002 B1
6387986 Moradi-Araghi et al. May 2002 B1
6390195 Nguyen et al. May 2002 B1
6394181 Schnatzmeyer et al. May 2002 B2
6401817 Griffith et al. Jun 2002 B1
6405796 Meyer et al. Jun 2002 B1
6405797 Davidson et al. Jun 2002 B2
6406789 McDaniel et al. Jun 2002 B1
6408943 Schultz et al. Jun 2002 B1
6415509 Echols et al. Jul 2002 B1
6422183 Kato Jul 2002 B1
6422314 Todd et al. Jul 2002 B1
6439309 Matherly et al. Aug 2002 B1
6439310 Scott, III et al. Aug 2002 B1
6440255 Kohlhammer et al. Aug 2002 B1
6446727 Zemlak et al. Sep 2002 B1
6448206 Griffith et al. Sep 2002 B1
6450260 James et al. Sep 2002 B1
6454003 Chang et al. Sep 2002 B1
6457518 Castano-Mears et al. Oct 2002 B1
6458885 Stengel et al. Oct 2002 B1
6478092 Voll et al. Nov 2002 B2
6485947 Rajgarhia et al. Nov 2002 B1
6488091 Weaver et al. Dec 2002 B1
6488763 Brothers et al. Dec 2002 B2
6494263 Todd Dec 2002 B2
6503870 Griffith et al. Jan 2003 B2
6508305 Brannon et al. Jan 2003 B1
6510896 Bode et al. Jan 2003 B2
6520255 Tolman et al. Feb 2003 B2
6527051 Reddy et al. Mar 2003 B1
6528157 Hussain et al. Mar 2003 B1
6531427 Shuchart et al. Mar 2003 B1
6534449 Gilmour et al. Mar 2003 B1
6536939 Blue Mar 2003 B1
6538576 Schultz et al. Mar 2003 B1
6543545 Chatterji et al. Apr 2003 B1
6550959 Huber et al. Apr 2003 B2
6552333 Storm et al. Apr 2003 B1
6554071 Reddy et al. Apr 2003 B1
6555507 Chatterji et al. Apr 2003 B2
6569814 Brady et al. May 2003 B1
6582819 McDaniel et al. Jun 2003 B2
6588926 Huber et al. Jul 2003 B2
6588928 Huber et al. Jul 2003 B2
6593402 Chatterji et al. Jul 2003 B2
6599863 Palmer et al. Jul 2003 B1
6608162 Chiu et al. Aug 2003 B1
6609578 Patel et al. Aug 2003 B2
6616320 Huber et al. Sep 2003 B2
6620857 Valet Sep 2003 B2
6626241 Nguyen Sep 2003 B2
6632527 McDaniel et al. Oct 2003 B1
6632778 Ayoub et al. Oct 2003 B1
6632892 Rubinsztajn et al. Oct 2003 B2
6642309 Komitsu et al. Nov 2003 B2
6648501 Huber et al. Nov 2003 B2
6659179 Nguyen Dec 2003 B2
6664343 Narisawa et al. Dec 2003 B2
6667279 Hessert et al. Dec 2003 B1
6668926 Nguyen et al. Dec 2003 B2
6669771 Tokiwa et al. Dec 2003 B2
6677426 Noro et al. Jan 2004 B2
6681856 Chatterji et al. Jan 2004 B1
6686328 Binder Feb 2004 B1
6705400 Nguyen et al. Mar 2004 B1
6705440 Nugyen et al. Mar 2004 B2
6710019 Sawdon et al. Mar 2004 B1
6713170 Kaneko et al. Mar 2004 B1
6725926 Nguyen et al. Apr 2004 B2
6725930 Boney et al. Apr 2004 B2
6725931 Nguyen et al. Apr 2004 B2
6729404 Nguyen et al. May 2004 B2
6729405 DiLullo et al. May 2004 B2
6732800 Acock et al. May 2004 B2
6745159 Todd et al. Jun 2004 B1
6749025 Brannon et al. Jun 2004 B1
6763888 Harris et al. Jul 2004 B1
6764981 Eoff et al. Jul 2004 B1
6766858 Nguyen et al. Jul 2004 B2
6776235 England Aug 2004 B1
6776236 Nguyen Aug 2004 B1
6832650 Nguyen et al. Dec 2004 B2
6832655 Ravensbergen et al. Dec 2004 B2
6837309 Boney et al. Jan 2005 B2
6851474 Nguyen Feb 2005 B2
6866099 Nguyen Mar 2005 B2
6881709 Nelson et al. Apr 2005 B2
6887834 Nguyen et al. May 2005 B2
6962200 Nguyen et al. Nov 2005 B2
6978836 Nguyen et al. Dec 2005 B2
6997259 Nguyen Feb 2006 B2
7013976 Nguyen et al. Mar 2006 B2
7017665 Nguyen Mar 2006 B2
7025134 Byrd et al. Apr 2006 B2
7028774 Nguyen et al. Apr 2006 B2
7032667 Nguyen et al. Apr 2006 B2
7036589 Nguyen May 2006 B2
7040403 Nguyen et al. May 2006 B2
7059406 Nguyen Jun 2006 B2
7063150 Slabaugh et al. Jun 2006 B2
7066258 Justus et al. Jun 2006 B2
7073581 Nguyen et al. Jul 2006 B2
7080688 Todd et al. Jul 2006 B2
7081439 Sullivan et al. Jul 2006 B2
7093658 Chatterji et al. Aug 2006 B2
7104325 Nguyen et al. Sep 2006 B2
7114560 Nguyen et al. Oct 2006 B2
7114570 Nguyen et al. Oct 2006 B2
7117942 Dalrymple et al. Oct 2006 B2
7131491 Blauch et al. Nov 2006 B2
7153575 Anderson et al. Dec 2006 B2
7156194 Nguyen Jan 2007 B2
7178596 Blauch et al. Feb 2007 B2
7204311 Welton et al. Apr 2007 B2
7210528 Brannon et al. May 2007 B1
7216711 Nguyen et al. May 2007 B2
7252146 Slabaugh et al. Aug 2007 B2
7261156 Nguyen et al. Aug 2007 B2
7264051 Nguyen et al. Sep 2007 B2
7264052 Nguyen et al. Sep 2007 B2
7267717 Watanabe et al. Sep 2007 B2
7273099 East, Jr. et al. Sep 2007 B2
7281581 Nguyen et al. Oct 2007 B2
7306037 Nguyen et al. Dec 2007 B2
7343973 Dusterhoft et al. Mar 2008 B2
20010016562 Muir et al. Aug 2001 A1
20020036088 Todd Mar 2002 A1
20020043370 Poe Apr 2002 A1
20020048676 McDaniel et al. Apr 2002 A1
20020070020 Nguyen Jun 2002 A1
20020104217 Echols et al. Aug 2002 A1
20020160920 Dawson et al. Oct 2002 A1
20020169085 Miller et al. Nov 2002 A1
20020189808 Nguyen et al. Dec 2002 A1
20030006036 Malone et al. Jan 2003 A1
20030013871 Mallon et al. Jan 2003 A1
20030060374 Cooke, Jr. Mar 2003 A1
20030106690 Boney et al. Jun 2003 A1
20030114314 Ballard et al. Jun 2003 A1
20030114317 Benton et al. Jun 2003 A1
20030130133 Vollmer Jul 2003 A1
20030131999 Nguyen et al. Jul 2003 A1
20030148893 Lungofer et al. Aug 2003 A1
20030186820 Thesing Oct 2003 A1
20030188766 Banerjee et al. Oct 2003 A1
20030188872 Nguyen et al. Oct 2003 A1
20030196805 Boney et al. Oct 2003 A1
20030205376 Ayoub et al. Nov 2003 A1
20030230408 Acock et al. Dec 2003 A1
20030230431 Reddy et al. Dec 2003 A1
20030234103 Lee et al. Dec 2003 A1
20040000402 Nguyen et al. Jan 2004 A1
20040014607 Sinclair et al. Jan 2004 A1
20040014608 Nguyen et al. Jan 2004 A1
20040040706 Hossaini et al. Mar 2004 A1
20040040708 Stephenson et al. Mar 2004 A1
20040040712 Ravi et al. Mar 2004 A1
20040040713 Nguyen et al. Mar 2004 A1
20040043906 Heath et al. Mar 2004 A1
20040045712 Eoff et al. Mar 2004 A1
20040048752 Nguyen et al. Mar 2004 A1
20040055747 Lee Mar 2004 A1
20040060702 Kotlar et al. Apr 2004 A1
20040106525 Willbert et al. Jun 2004 A1
20040138068 Rimmer et al. Jul 2004 A1
20040149441 Nguyen et al. Aug 2004 A1
20040152601 Still et al. Aug 2004 A1
20040152602 Boles Aug 2004 A1
20040177961 Nguyen et al. Sep 2004 A1
20040194960 Nguyen et al. Oct 2004 A1
20040194961 Nguyen et al. Oct 2004 A1
20040206499 Nguyen et al. Oct 2004 A1
20040211559 Nguyen et al. Oct 2004 A1
20040211561 Nguyen et al. Oct 2004 A1
20040221992 Nguyen et al. Nov 2004 A1
20040231845 Cooke, Jr. Nov 2004 A1
20040231847 Nguyen et al. Nov 2004 A1
20040256097 Byrd et al. Dec 2004 A1
20040256099 Nguyen et al. Dec 2004 A1
20040261993 Nguyen Dec 2004 A1
20040261995 Nguyen et al. Dec 2004 A1
20040261997 Nguyen et al. Dec 2004 A1
20040261999 Nguyen Dec 2004 A1
20050000694 Dalrymple et al. Jan 2005 A1
20050000731 Nguyen et al. Jan 2005 A1
20050006093 Nguyen et al. Jan 2005 A1
20050006095 Justus et al. Jan 2005 A1
20050006096 Nguyen et al. Jan 2005 A1
20050028976 Nguyen Feb 2005 A1
20050028979 Brannon et al. Feb 2005 A1
20050034862 Nguyen Feb 2005 A1
20050034865 Todd et al. Feb 2005 A1
20050045326 Nguyen Mar 2005 A1
20050045330 Nguyen et al. Mar 2005 A1
20050045384 Nguyen Mar 2005 A1
20050051322 Nguyen et al. Mar 2005 A1
20050051331 Nguyen et al. Mar 2005 A1
20050059555 Dusterhoft et al. Mar 2005 A1
20050061509 Nguyen Mar 2005 A1
20050092489 Welton et al. May 2005 A1
20050126780 Todd et al. Jun 2005 A1
20050139359 Maurer et al. Jun 2005 A1
20050145385 Nguyen Jul 2005 A1
20050173116 Nguyen et al. Aug 2005 A1
20050178551 Tolman et al. Aug 2005 A1
20050194135 Nguyen et al. Sep 2005 A1
20050194136 Nguyen et al. Sep 2005 A1
20050194140 Dalrymple et al. Sep 2005 A1
20050194142 Nguyen Sep 2005 A1
20050197258 Nguyen Sep 2005 A1
20050207001 Laufer et al. Sep 2005 A1
20050257929 Nguyen et al. Nov 2005 A1
20050263283 Nguyen Dec 2005 A1
20050267001 Weaver et al. Dec 2005 A1
20050269086 Nguyen et al. Dec 2005 A1
20050269101 Stegent et al. Dec 2005 A1
20050274510 Nguyen et al. Dec 2005 A1
20050274517 Blauch et al. Dec 2005 A1
20050274520 Nguyen et al. Dec 2005 A1
20050277554 Blauch et al. Dec 2005 A1
20050284632 Dalrymple et al. Dec 2005 A1
20050284637 Stegent et al. Dec 2005 A1
20060048943 Parker et al. Mar 2006 A1
20060048944 van Batenburg et al. Mar 2006 A1
20060052251 Anderson et al. Mar 2006 A1
20060089266 Dusterhoft et al. Apr 2006 A1
20060113078 Nguyen et al. Jun 2006 A1
20060124303 Nguyen et al. Jun 2006 A1
20060124309 Nguyen et al. Jun 2006 A1
20060137875 Dusterhoft et al. Jun 2006 A1
20060157243 Nguyen Jul 2006 A1
20060175058 Nguyen Aug 2006 A1
20060219405 Nguyen et al. Oct 2006 A1
20060219408 Nguyen et al. Oct 2006 A1
20060234874 Eoff et al. Oct 2006 A1
20060240994 Eoff et al. Oct 2006 A1
20060240995 Rickman et al. Oct 2006 A1
20060260810 Weaver et al. Nov 2006 A1
20060260813 Welton et al. Nov 2006 A1
20060264332 Welton et al. Nov 2006 A1
20070007010 Welton et al. Jan 2007 A1
20070012445 Nguyen et al. Jan 2007 A1
20070114032 Stegent et al. May 2007 A1
20070131422 Gatlin et al. Jun 2007 A1
20070131425 Gatlin et al. Jun 2007 A1
20070251693 Cheramie et al. Nov 2007 A1
Foreign Referenced Citations (46)
Number Date Country
2063877 May 2003 CA
0313243 Oct 1988 EP
0528595 Aug 1992 EP
0506934 Oct 1992 EP
0510762 Nov 1992 EP
0643196 Jun 1994 EP
0834644 Apr 1998 EP
0853186 Jul 1998 EP
0864726 Sep 1998 EP
0879935 Nov 1998 EP
0933498 Aug 1999 EP
1001133 May 2000 EP
1132569 Sep 2001 EP
1326003 Jul 2003 EP
1362978 Nov 2003 EP
1394355 Mar 2004 EP
1396606 Mar 2004 EP
1398460 Mar 2004 EP
1403466 Mar 2004 EP
1464789 Oct 2004 EP
1607572 Dec 2005 EP
1107584 Apr 1965 GB
1264180 Dec 1969 GB
1292718 Oct 1972 GB
2298440 Sep 1996 GB
2382143 Apr 2001 GB
WO 9315127 Aug 1993 WO
WO 9407949 Apr 1994 WO
WO 9408078 Apr 1994 WO
WO 9408090 Apr 1994 WO
WO 9509879 Apr 1995 WO
WO 9711845 Apr 1997 WO
WO 9927229 Jun 1999 WO
WO 0181914 Nov 2001 WO
WO 0187797 Nov 2001 WO
WO 0212674 Feb 2002 WO
WO 03027431 Apr 2003 WO
WO 03027431 Apr 2003 WO
WO 2004009956 Jan 2004 WO
WO 2004037946 May 2004 WO
WO 2004038176 May 2004 WO
WO 2004083600 Sep 2004 WO
WO2004090281 Oct 2004 WO
WO2004104368 Dec 2004 WO
WO 2005021928 Mar 2005 WO
WO2005080749 Sep 2005 WO
Related Publications (1)
Number Date Country
20080006406 A1 Jan 2008 US